Difference between revisions of "Part:BBa M1000"

 
 
(2 intermediate revisions by 2 users not shown)
Line 1: Line 1:
−
 
 
__NOTOC__
 
__NOTOC__
 
<partinfo>BBa_M1000 short</partinfo>
 
<partinfo>BBa_M1000 short</partinfo>
  
−
Left end of a linear transpososome sequence containing the 19 bp mosaic end in the forward orientation.  The sequence also contains a PvuII cut site which releases the transpososome when cut with PvuII.  Constructed compound parts intended for transposition must not contain other PvuII end, or be PCR amplified with blunt end producing enzymes (Pfu, Phusion) at the PvuII cut site between CAG and CTG.
+
*Left end of a linear transposome sequence containing the 19 bp mosaic end in the forward orientation.  The sequence also contains a PvuII cut site which releases the transpososome when cut with PvuII.  Constructed compound parts intended for transposition must not contain other PvuII cut sites, or be PCR-amplified with blunt-end-producing enzymes (Pfu, Phusion) at the PvuII cut site between CAG and CTG.
  
−
This part, and the companion part M1001 provide Biobrick tools to construct Tn5 transpososomes: linear DNA sequences which can be cut in vitro from a plasmid backbone, or created by PCR, combined in vitro with purified Tn5 trasposase protein, electroportated into cells, and finally randomly inserting into the bacterial chromosome.
+
*This part, and the companion part M1001 provide BioBrick tools to construct Tn5 transposomes: linear DNA sequences which can be cut ''in vitro'' from a plasmid backbone, or created by PCR, combined ''in vitro'' with purified Tn5 transposase protein, electroportated into cells, and finally randomly insert into the bacterial chromosome.
−
The parts assembled between the two mosaic ends can be delivered, including antibiotic resistance markers or other  functional chromosomal insertions.
+
*The parts assembled between the two mosaic ends can be delivered, including antibiotic resistance markers or other  functional chromosomal insertions.
  
  
 +
<!-- Add more about the biology of this part here
 
===Usage and Biology===
 
===Usage and Biology===
−
-- Please enter your experience with this part here --
 
  
 +
<!-- -->
 
<span class='h3bb'>Sequence and Features</span>
 
<span class='h3bb'>Sequence and Features</span>
 
<partinfo>BBa_M1000 SequenceAndFeatures</partinfo>
 
<partinfo>BBa_M1000 SequenceAndFeatures</partinfo>
  
 +
 +
<!-- Uncomment this to enable Functional Parameter display
 
===Functional Parameters===
 
===Functional Parameters===
 
<partinfo>BBa_M1000 parameters</partinfo>
 
<partinfo>BBa_M1000 parameters</partinfo>
 +
<!-- -->

Latest revision as of 20:38, 12 April 2007

Left mosaic end for Tn5 transpososome

  • Left end of a linear transposome sequence containing the 19 bp mosaic end in the forward orientation. The sequence also contains a PvuII cut site which releases the transpososome when cut with PvuII. Constructed compound parts intended for transposition must not contain other PvuII cut sites, or be PCR-amplified with blunt-end-producing enzymes (Pfu, Phusion) at the PvuII cut site between CAG and CTG.
  • This part, and the companion part M1001 provide BioBrick tools to construct Tn5 transposomes: linear DNA sequences which can be cut in vitro from a plasmid backbone, or created by PCR, combined in vitro with purified Tn5 transposase protein, electroportated into cells, and finally randomly insert into the bacterial chromosome.
  • The parts assembled between the two mosaic ends can be delivered, including antibiotic resistance markers or other functional chromosomal insertions.


Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]